The Wall Street Journal: Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a...